24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Aya Jakobovits
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:23
Palo Alto Networks to buy Protect AI for estimated hundreds of millions amid AI security race
16:51
Full list of Israeli startup M&As in 2025
16:30
Upwind acquires Nyx Security to strengthen real-time cloud application protection
15:30
Lightrun raises $70 million to bring AI-powered real-time remediation to enterprise software
More stories
Buzz
Most popular
Daily
Weekly
1
Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
2
Intel’s AI reset highlights hard lessons from Israeli acquisitions
3
Intel cancels Intel Capital spinoff as Lip-Bu Tan shifts to financial discipline
4
Adam Neumann’s Flow raises over $100M at $2.5B valuation
5
Intel-backed Ignite DeepTech launches first cohort in Israel
More news
Aya Jakobovits
2 stories about Aya Jakobovits
Covid-19 was one of the biomed industry’s finest hours, says Israeli Silicon Valley veteran
15.12.20
|
Ron Friedman
Aya Jakobovits, a trailblazer in the biomed sector who is participating in J-Ventures’ annual investor’s conference, speaks of how the coronavirus vaccines showcased the depth of new technology
Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
02.10.19
|
Meir Orbach
Founded by Israeli chemist Aya Jakobovits, Adicet develops universal immune cell therapies based on gamma delta T cells to treat different forms of cancer